«
»

Human Genome shares rise on ABthrax order (AP)


Shares of Human Genome Sciences Inc. rose Wednesday after the biotechnology company said the U.S. government placed an additional $151 million order for the inhaled anthrax treatment ABthrax.

This entry was posted on Wednesday, July 22nd, 2009, 7:51 pm and is filed under Finance News. You can follow any responses to this entry through RSS 2.0. Both comments and pings are currently closed.

Comments are closed.